Status:
COMPLETED
Single Dose Study Of PF-04171327 And Prednisone On Carbohydrate Metabolism
Lead Sponsor:
Pfizer
Conditions:
Healthy
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
This study will investigate the effect of a single dose of PF-04171327 or prednisone on calculated measures of glucose tolerance and insulin resistance by using a modified oral glucose tolerance test
Eligibility Criteria
Inclusion
- BMI 17.5 to 30.5 kg/m2 and total body weight \>50 kg
Exclusion
- Fasting glucose above the limits of the reference range for healthy individuals
- "No treatment" Oral Glucose Tolerance Test (OGTT) indicative of impaired fasting glucose or impaired glucose tolerance
- Severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01199900
Start Date
August 1 2010
End Date
September 1 2010
Last Update
December 17 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Kalamazoo, Michigan, United States, 49007